|
Indian Pediatr 2020;57: 81-82 |
|
Early-onset Fulminant Subacute Sclerosing Panencephalitis in
a Toddler
|
Prateek Kumar Panda and Indar Kumar Sharawat*
Pediatric Neurology Division, Department of Pediatrics,
All India Institute of Medical Sciences,
Rishikesh, Uttarakhand. India.
Email:
[email protected]
|
A 22-month-old boy born to non-consanguineous parents with pre-morbid
normal development, presented with loss of previously acquired
developmental milestones and recurrent head drops for the past 3 months.
He was completely unimmunized and had a history of exanthematous febrile
illness resembling measles at the age of 11 months. On examination, he
was in a minimally conscious state, with generalized dystonia,
intermittent choreoathetosis and repetitive myoclonic jerks.
Electroencephalography showed generalized periodic
epileptiform discharges, with bursts comprising of high amplitude spike
and slow-wave complexes. MRI brain showed patchy periventricular white
matter signal changes. CSF measles specific IgG levels were elevated
(1:625), confirming the diagnosis of subacute sclerosing panencephalitis
(SSPE). He was started on isoprinosine and antiepileptic drugs. At 6
week follow up, myoclonic jerks had subsided; however, he was in
vegetative state and had persistent extrapyramidal features.
Neurological syndromes caused by measles virus
include primary measles encephalitis, acute post-measles encephalitis,
inclusion-body encephalitis and SSPE [1]. SSPE is caused by latent
smoldering infection of the brain by wild-type measles virus
which has variable presentation
and is frequently misdiagnosed [2]. The earliest documented case of SSPE
following a postnatally acquired measles infection was at 10 months of
age [3]. A total of 15 cases of SSPE have been diagnosed before three
years of age [1] of which seven cases occurred following postnatally
acquired measles infection.
The clinical course of SSPE was atypical, did not
follow the classic four stages of the Jabbour Classification [1] and had
history of pre-existing developmental delay or seizures. As compared to
older children, course of the disease was fulminant with rapid
progression to a vegetative state and fatal outcome [4]. Genetically
determined immune dysfunction in the first 2 years of life preventing a
successful cell-mediated immune clearance of measles virus has been
implicated in this short latency and fulminant course [5]. Other
putative genetic factors include genetic polymorphisms of Toll-like
receptor 3, programmed cell death-1, MxA, interleukin-4, and
interferon-1 genes [5]. Clinicians need to be aware of these important
clinical observations to suspect atypical presentation of SSPE in young
children. Although neuronal ceroid lipofuscinosis and other lysosomal
storage diseases remain the most plausible clinical differentials for
progressive myoclonic epilepsy with onset less than two years of age,
SSPE should be considered in an unimmunized toddler who presents with
cognitive decline, extrapyramidal signs and symptoms, myoclonus and a
rapidly progressive fulminant course particularly in developing
countries.
References
1. Kasinathan
A, Sharawat IK, Kesavan S, Suthar R, Sankhyan N. Early-onset subacute
sclerosing panencephalitis: Report of two cases and review of
literature. Ann Indian Acad Neurol. 2019;22:361-3.
2. Campbell H,
Andrews N, Brown KE, Miller E. Review of the effect of measles
vaccination on the epidemiology of SSPE. Int J Epidemiol.
2007;36:133448.
3. Saurabh K, Gupta R, Khare S, Sharma S. Atypical
subacute sclerosing panencephalitis with short onset latency. Indian
Pediatr. 2013;50:244-5.
4. Anlar B. Subacute sclerosing panencephalitis and
chronic viral encephalitis. Handb Clin Neurol. 2013;112:1183-9.
5. Gutierrez J, Issacson RS, Koppel BS. Subacute sclerosing
panencephalitis: An update. Dev Med Child Neurol. 2010;52:901-7.
|
|
|
|